# Stephen Salloway

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stephen-salloway/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,198 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 108 |
| i10-index | 339 |
| OpenAlex ID | https://openalex.org/A5002183686 |
| ORCID iD | https://orcid.org/0000-0002-2631-0942 |
| Works | 612 |

## Researcher papers

- [Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease](https://scholariq.org/papers/clinical-and-biomarker-changes-in-dominantly-inherited-alzheimer-s-disease/)
- [Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria](https://scholariq.org/papers/advancing-research-diagnostic-criteria-for-alzheimer-s-disease-the-iwg-2/)
- [Donanemab in Early Symptomatic Alzheimer Disease](https://scholariq.org/papers/donanemab-in-early-symptomatic-alzheimer-disease/)
- [Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria](https://scholariq.org/papers/preclinical-alzheimer-s-disease-definition-natural-history-and-diagnostic/)
- [Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study](https://scholariq.org/papers/spatial-patterns-of-neuroimaging-biomarker-change-in-individuals-from-families/)
- [Efficacy and Tolerability of Donepezil in Vascular Dementia](https://scholariq.org/papers/efficacy-and-tolerability-of-donepezil-in-vascular-dementia/)
- [Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease](https://scholariq.org/papers/safety-and-tolerability-of-the-secretase-inhibitor-avagacestat-in-a-phase-2/)
- [Targeting Prodromal Alzheimer Disease With Avagacestat](https://scholariq.org/papers/targeting-prodromal-alzheimer-disease-with-avagacestat/)
- [Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials](https://scholariq.org/papers/amyloid-sup-11-sup-c-pib-pet-imaging-results-from-2-randomized-bapineuzumab/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)
- [Advanced Neuroimaging Techniques and Applications](https://scholariq.org/topics/advanced-neuroimaging-techniques-and-applications/)
- [Intracerebral and Subarachnoid Hemorrhage Research](https://scholariq.org/topics/intracerebral-and-subarachnoid-hemorrhage-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.